Zentek (ZTEK) Return on Capital Employed (2022 - 2026)
Zentek (ZTEK) posted quarterly Return on Capital Employed of 83.5% for Q1 2026, up 2668.0% year-on-year from 3.02% in Q1 2025, and up 55.41% on a QoQ basis from 187.24% in Q4 2025.
Zentek (ZTEK) Return on Capital Employed (2022 - 2026) Analysis & Trends
Zentek (ZTEK) has reported Return on Capital Employed for 5 consecutive years, with 83.5% the latest figure, recorded in Q1 2026.
- Quarterly Return on Capital Employed rose 2668.0% year-over-year to 83.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 83.5% (up 2668.0% YoY) and the FY2026 annual result came in at 83.46%, down 2812.0% from the prior year.
- Return on Capital Employed climbed to 83.5% in Q1 2026 per ZTEK's latest filing, from 187.24% in the prior quarter.
- Over the last five years, Return on Capital Employed for ZTEK reached as high as 65.5% in Q4 2022 and fell as low as 187.24% in Q4 2025.
- A 5-year average of 52.59% and a median of 71.64% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 11210 bps — and 2025, when it sank 19752 bps.
- Year by year, Return on Capital Employed stood at 65.5% in 2022, then slumped by 255 bps to 101.82% in 2023, then surged by 110 bps to 10.28% in 2024, then tumbled by 1922 bps to 187.24% in 2025, then jumped by 55 bps to 83.5% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 83.5%, 187.24%, and 144.27% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Zentek | 57.20 Mn | 56.25 Mn | -979,642.64 | -83.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83.50% |
| Dec 31, 2025 | -187.24% |
| Sep 30, 2025 | -144.27% |
| Jun 30, 2025 | -102.43% |
| Mar 31, 2025 | -110.18% |
| Dec 31, 2024 | 10.28% |
| Sep 30, 2024 | 14.32% |
| Jun 30, 2024 | 19.81% |
| Mar 31, 2024 | 13.82% |
| Dec 31, 2023 | -101.82% |
| Sep 30, 2023 | -85.04% |
| Jun 30, 2023 | -71.64% |
| Mar 31, 2023 | -64.04% |
| Dec 31, 2022 | 65.50% |
| Sep 30, 2022 | 37.56% |